Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here’s Why You Shouldn’t Focus on Blackberry’s Results and Still Go Long

Page 1 of 2

With the NASDAQ up modestly in afternoon trade, Blackberry Ltd (NASDAQ:BBRY)’s stock has slid by over 5% on the back of the release of financial results for the second quarter of fiscal year 2015. The technology company reported a loss of $0.13 per share, versus expectations of a loss of $0.09 per share. The company’s  revenue was $490 million, significantly lower than the estimates of $611 million. Despite such weak results and amid a 38% drop of the stock, hedge funds seem to like Blackberry, as they held over 15% of the company at the end of June.

Best Smartphones with Removable Batteries

We mention the hedge fund sentiment towards Blackberry Ltd (NASDAQ:BBRY) because our research has shown that historically their stock picks delivered superior risk-adjusted returns. This is especially true in the small-cap space. The 50 most popular large-cap stocks among hedge funds had a monthly alpha of about six basis points per month between 1999 and 2012; however the 15 most popular small-cap stocks delivered a monthly alpha of 80 basis points during the same period. This means investors would have generated 10 percentage points of alpha per year simply by imitating hedge funds’ top 15 small-cap ideas. We have been tracking the performance of these stocks since the end of August 2012 in real time and these stocks beat the market by 60 percentage points (118% return vs. the S&P 500’s 57.6% gain) over the last 36 months (see the details here).

Follow Blackberry Ltd (NASDAQ:BBRY)
Trade (NASDAQ:BBRY) Now!

Blackberry Ltd (NASDAQ:BBRY)’s hardware division revenue was weak, with sales of $200 million, compared to analyst expectations of $263 million. Software revenue was tepid as well, with division revenue of $74 million, below expectations of $100 million, while services revenue was $210 million, compared to the expected $227 million. In addition to, disappointing revenue numbers, gross margin also stood below the expectations at 37.8%. Blackberry’s guidance wasn’t strong either, with management expecting ‘modest’ sequential revenue growth for the remainder of fiscal 2016.

The earnings results weren’t all bad, however. Blackberry bought back six million shares in the second quarter and has plans to repurchase up to 15 million more shares. The company generated a free cash flow of $100 million, marking the sixth consecutive quarter of positive free cash flow. Management is looking forward to launching a new ‘Priv’ phone in the coming months and noted that Blackberry continues to lead in mobile security and will bring its security know-how into the Android ecosystem for the first time ever with its phone.

Hedge funds are bullish on Blackberry, as it has been stated earlier. Our data show that the aggregate value of hedge fund holdings in Blackberry increased to $653 million (15.1% of the float) at the end of June from $624 million in the prior quarter. Seven of the top 10 shareholders from our database increased their positions in Blackberry, while one hedge fund reduced its stake. Overall, 23 funds were long Blackberry at the end of June, down slightly from 27 funds a quarter earlier. Jim Simons’ Renaissance Technologies increased its position by 62% to 5.99 million shares, while Cliff Asness’ AQR Capital Management upped its stake by 103% to 3.81 million shares. David Shaw’s D.E. Shaw raised its position by 135% to 2.91 million shares and Ken Griffin’s Citadel Investment Group upped its holdings by 61% to 1.56 million shares. Joel Greenblatt’s Gotham Asset management was extremely bullish, increasing its position by 4,256% to 1.69 million shares, while Prem Watsa‘s Fairfax Financial Holdings kept its position the same at 46.7 million shares.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!